JP2010285434A5 - - Google Patents

Download PDF

Info

Publication number
JP2010285434A5
JP2010285434A5 JP2010142292A JP2010142292A JP2010285434A5 JP 2010285434 A5 JP2010285434 A5 JP 2010285434A5 JP 2010142292 A JP2010142292 A JP 2010142292A JP 2010142292 A JP2010142292 A JP 2010142292A JP 2010285434 A5 JP2010285434 A5 JP 2010285434A5
Authority
JP
Japan
Prior art keywords
disease
use according
retinopathy
vascular
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010142292A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010285434A (ja
JP5385219B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010285434A publication Critical patent/JP2010285434A/ja
Publication of JP2010285434A5 publication Critical patent/JP2010285434A5/ja
Application granted granted Critical
Publication of JP5385219B2 publication Critical patent/JP5385219B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2010142292A 2002-07-25 2010-06-23 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法 Expired - Fee Related JP5385219B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39852202P 2002-07-25 2002-07-25
US60/398,522 2002-07-25
US46705103P 2003-05-02 2003-05-02
US60/467,051 2003-05-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005505648A Division JP2005538742A (ja) 2002-07-25 2003-07-25 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法

Publications (3)

Publication Number Publication Date
JP2010285434A JP2010285434A (ja) 2010-12-24
JP2010285434A5 true JP2010285434A5 (https=) 2011-10-13
JP5385219B2 JP5385219B2 (ja) 2014-01-08

Family

ID=31191212

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005505648A Pending JP2005538742A (ja) 2002-07-25 2003-07-25 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法
JP2010142292A Expired - Fee Related JP5385219B2 (ja) 2002-07-25 2010-06-23 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005505648A Pending JP2005538742A (ja) 2002-07-25 2003-07-25 造血幹細胞及び該細胞を使用して眼の新生血管の疾患を治療する方法

Country Status (17)

Country Link
US (2) US7153501B2 (https=)
EP (1) EP1542536B1 (https=)
JP (2) JP2005538742A (https=)
KR (2) KR20110102961A (https=)
CN (1) CN1307300C (https=)
AT (1) ATE536405T1 (https=)
AU (1) AU2003259687B2 (https=)
BR (1) BR0312920A (https=)
CA (1) CA2493122C (https=)
DK (1) DK1542536T3 (https=)
ES (1) ES2376866T3 (https=)
MX (1) MXPA05000972A (https=)
PL (1) PL216193B1 (https=)
PT (1) PT1542536E (https=)
RU (1) RU2331669C2 (https=)
WO (2) WO2004010959A2 (https=)
ZA (1) ZA200500682B (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006031467A2 (en) * 2002-07-25 2006-03-23 The Scripps Research Institute Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
US20060104963A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
US20060104962A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
CA2524063C (en) * 2003-05-02 2015-02-17 The Scripps Research Institute Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
WO2005042731A1 (en) * 2003-10-31 2005-05-12 Children's Medical Center Corporation Methods for purifying hematopoietic stem cells
RU2279886C2 (ru) * 2004-06-10 2006-07-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Минздрава РФ Способ улучшения функциональной активности сетчатки при ее патологии различного генеза
US8282921B2 (en) 2004-08-02 2012-10-09 Paul Glidden tRNA synthetase fragments
CA2574186A1 (en) * 2004-08-13 2006-02-23 Medtronic, Inc. Isolation of endothelial progenitor cell subsets and methods for their use
CA2579292A1 (en) * 2004-09-03 2006-03-23 The Scripps Research Institute Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
DE102004055615A1 (de) * 2004-11-16 2006-05-18 Universitätsklinikum Hamburg-Eppendorf In vitro aus Knochenmarkstammzellen differenzierte Retina-spezifische Zellen, ihre Herstellung und Verwendung
US20080317721A1 (en) * 2005-02-24 2008-12-25 The Scripps Research Institute Method for the Treatment of Retinopathy of Prematurity and Related Retinopathic Diseases
US20070231306A1 (en) * 2005-02-24 2007-10-04 The Scripps Research Institute Isolated myeloid-like cell populations and methods of treatment therewith
BRPI0608272A2 (pt) * 2005-02-24 2009-12-08 Scripps Research Inst método para promover revascularização fisiológica benéfica de tecido retinal isquêmico e método de triagem para identificar e avaliar a eficácia terapêutica de agentes terapêuticos potenciais para tratar doenças neovasculares retinais
CA2598029A1 (en) * 2005-02-24 2006-10-05 The Scripps Research Institute Isolated myeloid-like bone marrow cell populations and methods of treatment therewith
JP4734636B2 (ja) * 2005-11-02 2011-07-27 国立大学法人 鹿児島大学 免疫染色法、及び当該免疫染色法を利用した細胞の評価方法
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
EP1951864B1 (en) 2005-11-07 2014-05-07 Amorcyte, Inc. Compositions and methods of vascular injury repair
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
JP5649786B2 (ja) 2006-03-07 2015-01-07 ギータ シュロフ ヒト胚性幹細胞およびそれらの誘導体を含む組成物、使用方法、ならびに調製方法
KR100757265B1 (ko) * 2006-04-27 2007-09-10 (주) 차바이오텍 제대혈 유래 줄기 세포를 포함하는 요실금 치료용 조성물
WO2008006168A1 (en) * 2006-07-12 2008-01-17 Angioblast Systems, Inc. Treatment of excessive neovascularization
JP5372764B2 (ja) * 2006-11-07 2013-12-18 シャイア リジェネラティブ メディシン, インコーポレイテッド 血管形成関連疾患の治療および管理のための材料および方法
US20100098675A1 (en) * 2008-05-30 2010-04-22 Nikolai Tankovich Methods for reducing the side effects of ophthalmic laser surgery
EP2331679B1 (en) * 2008-09-12 2017-04-19 Cryopraxis Criobiologia LTDA. Ischemic tissue cell therapy
RU2497532C2 (ru) 2008-12-03 2013-11-10 Эморсайт, Инк. Композиции, улучшающие перфузию в области инфаркта и способы восстановления сосудистого повреждения
RU2428956C2 (ru) * 2009-07-13 2011-09-20 Александр Дмитриевич Ромащенко Способ лечения атрофии зрительного нерва посредством трансплантации аутологичных стволовых клеток
WO2012005763A1 (en) 2010-07-06 2012-01-12 The Scripps Research Institute Use of myeloid-like progenitor cell populations to treat tumors
CA2853379C (en) 2011-10-27 2020-11-24 Wellstat Ophthalmics Corporation Vectors encoding rod-derived cone viability factor
EP2838995A4 (en) * 2012-04-16 2016-01-06 Univ California EYE THERAPEUTICS WITH MICROVESICLES FROM EMBRYONAL STEM CELLS
KR102254082B1 (ko) 2012-08-24 2021-05-18 고쿠리쓰 겐큐 가이하쓰 호징 리가가쿠 겐큐소 망막 색소 상피 세포 시트의 제조 방법
WO2020172854A1 (en) * 2019-02-28 2020-09-03 Shenzhen University Use of endothelial progenitor cells (epcs) in rejuvenating microvasculature, preventing aging and treating age-related diseases
CN121550400A (zh) * 2026-01-26 2026-02-24 天津医科大学眼科医院 Crybb2重组蛋白在治疗和/或预防糖尿病性视网膜病变中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27055C2 (uk) * 1993-12-14 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
US6908763B1 (en) * 1997-08-22 2005-06-21 The Board Of Trustees Of The Leland Stanford Junior University Mammalian common lymphoid progenitor cell
IL139034A0 (en) * 1998-04-28 2001-11-25 Nycomed Imaging As Improvements in or relating to separation processes
US6767737B1 (en) * 1998-08-31 2004-07-27 New York University Stem cells bearing an FGF receptor on the cell surface
US6780627B1 (en) * 2000-01-31 2004-08-24 Millennium Pharmaceuticals, Inc. 22438, 23553, 25278, and 26212 novel human sulfatases
US20020061587A1 (en) * 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
ATE420653T1 (de) * 2001-02-23 2009-01-15 Scripps Research Inst Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese
EP1490107A4 (en) * 2002-03-21 2005-11-09 Univ Florida MODULATION OF ANGIOGENESIS
WO2004005531A2 (en) * 2002-07-05 2004-01-15 Roger Williams Medical Center Targeting and tracking of cells to specific organs and tissues in vivo

Similar Documents

Publication Publication Date Title
JP2010285434A5 (https=)
Delplace et al. Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions
PH12019500423A1 (en) Pharmaceutical composition
JP2015096556A5 (https=)
AU2017234378B2 (en) Colony forming medium and use thereof
Ciccocioppo et al. Regenerative medicine: the red planet for clinicians
JP2016510727A5 (https=)
Bray et al. Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas
MY176514A (en) Compositions and methods for treating ocular edema, neovascularization and related diseases
EA201170551A1 (ru) Способы лечения заболеваний глаз
BR112014008759A2 (pt) tratamento de doença ocular
TW201138791A (en) Angiogenesis using placental stem cells
IN2015DN00017A (https=)
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
JP5926447B2 (ja) 血管内投与に適した大きさを持つ幹細胞の製造方法
JP2014527407A5 (https=)
CA2940691C (en) Method for generating endothelial colony forming cell-like cells
BR112015009229A2 (pt) composição tendo como alvo a expressão de genes para plaquetas, célula tronco hematopoiética, uso da referida célula tronco e método in vitro ou ex vivo para gerar uma célula tronco modificada
EP4534650A3 (en) Differentiation of human ips cells to human alveolar type ii via definitive endoderm
AR113562A1 (es) Método para inhibir la angiogénesis
Liu et al. Corneal stromal mesenchymal stem cells: reconstructing a bioactive cornea and repairing the corneal limbus and stromal microenvironment
SG11201804755VA (en) Method for manufacturing tissue/organ by using blood cells
AR079683A1 (es) Formulacion topica oftalmica de peptidos
Haghighat et al. Effect of β-carotene on the differentiation potential of ciliary epithelium-derived MSCs isolated from mouse eyes on alginate-based scaffolds
Proulx et al. Optimization of culture conditions for porcine corneal endothelial cells